Diabetes and hypertension have serious negative effects on morbidity rates and the person’s wellbeing. This study documents the decrease of medication use and improvement of glucose levels among overweight and obese diabetics.
Seven years of data were analyzed. Participants with type 2 diabetes voluntarily participated to an 18-day residential medical program. The intervention consisted of accompanying participants through lifestyle changes and was carried out by a multidisciplinary team.This intervention mainly incorporated: a varied whole foods plant based diet (high in fibers and low in saturated fat), regular physical exercise,adequate rest and spiritual counseling. Baseline bloodworks were obtain before and after the intervention. The systolic blood pressure (SBP) with the posology of current antihypertensive drugs was recorded at day 1 and day 14. Capillary glycemia and blood pressure were assessed daily.
Serum glucose levels decreased among diabetic (125 mg/dL and above) and overweight participants (>24.9.BMI).The baseline glucose at the start of the program for diabetic participants was 181 mg/dL (p<0.001; n=233). At the end of the program, the average for the same participants was 146.2 mg/dL (p<0.001; n=233). The antihypertensive medications that were measured are as follows: bisoprolol, losartan, and olmesartan. The average dosage of olmesartan taken at the start of the program was 1.63 pills/day (p<0.001; n=121). At the end of the program, the average pills/day for olmesartan had decreased to 0.80 (p<0.001; n=121). bisoprolol dosage had decreased from 1.85 pills/day to 0.92 pills/day (p<0.001; n=65). olmesartan intake had decreased from 1.88 pills/day to 0.94 pills/day (p<0.001; n=66).
Although this lifestyle intervention program lasted 18 days and the results were taken on day 14, we can infer that if the program was followed on a long-term basis, then greater results would occur. Encouragement of these lifestyle interventions should be promoted.